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Introduction: Autogenous bone grafting is commonly used in reconstructive surgery but
postoperative pain from the donor site can be severe, delaying early mobilisation and pre-
venting discharge from hospital.
Method: An RCT of levobupivacaine infusion (16.25 mg/h for 24 h) of iliac crest wounds ver-
sus placebo. Postoperative pain was recorded immediately on returning to the ward, then
at 1, 2, 3, 4, 5, 6 h, morning and evening on subsequent days until discharge, and at the 7-
day clinic appointment. Mobility was recorded twice daily and at 7 days.
Results: Of 46 evaluable patients, 25 were randomised to levobupivacaine and 21 to placebo.
Mean pain scores for (i) average pain from initial assessment to 6 h; (ii) 1 day in the morn-
ing; (iii) 1 day in the evening; (iv) at 2 days; and (v) follow-up were all statistically significant
in favour of lower pain scores in the levobupivicaine group ( p-values all <0.01). Compari-
son between the study groups for mobility found 6 patients unable to get out of bed in the
placebo group and none in the local anaesthetic group at the initial assessment (Fisher’s
exact test p-value ¼ 0.005), and 2 patients at 24 h. Patients in the local anaesthetic group
were always more mobile and this was statistically significant even at 7 days for gait dis-
turbance, limp, deviation of gait and unequalness of stride. There were no complications
relating to the infusion system.
Conclusions: Local anaesthetic significantly reduced postoperative pain and improved mo-
bility. We recommend that surgeons use a local anaesthetic infusion to improve the post-
operative experience for their patients undergoing iliac crest grafting.
ª 2007 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction potential complications. The ilium is frequently the site ofAutogenous grafting providesmaterial for reconstruction that
is free from any risk of infectivity1–3 but is not without other6650; fax þ44 (0)161 275 6
ter.ac.uk (P. Coulthard).
al Associates Ltd. Publishchoice for the harvesting of bone4,5 and several different sur-
gical techniques have been developed with the aim of reduc-
ing the associated morbidity.3,6–8 Despite this, postoperative631.
ed by Elsevier Ltd. All rights reserved.
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ment for systemic analgesia, delaying early mobilisation and
preventing discharge from hospital.9,10 Less commonly the
donor site procedure may cause chronic pain that is more
problematic than the primary surgical procedure itself.11
Although, local anaesthetic infusion to the harvest site has
been advocated as a safe and effective method of reducing
pain9,12 the efficacy has not been studied in a controlled fash-
ion and not all studies have demonstrated better pain con-
trol.13 The aim of our study was to use a randomised
controlled trial to investigate whether the post-operative ex-
perience of patients following iliac bone harvesting could be
improved by reducing the pain experienced. Our chosen
model was anterior iliac crest bone harvesting for the recon-
struction of the mandible and maxilla. The anterior iliac crest
is regarded as the donor site of choice for oral and maxillofa-
cial reconstructive surgery9,14,15 as it provides access to a large
quantity of donor bone with the patient in a supine position
such that simultaneous operating at hip and the head and
neck recipient site may occur, therefore reducing the opera-
tive and anaesthesia time.6 It is possible that the efficacy of
a local anaesthetic infusion could be impaired when a drain
is placed to the same site as this may lead to loss of the local
anaesthetic solution. However, the requirement for a drain
may be essential in some cases and so we elected to use a vac-
uum drain for all patients in this study.
Our hypothesis was that by using a continuous administra-
tion of local anaesthetic for 24 h via a catheter to the wound,
patients would wake up pain free and experience less postop-
erative pain, promoting earlier mobilisation and discharge.
Our primary efficacy variable was postoperative pain intensity
and our secondary outcomes of interest weremobility, time to
hospital discharge, and any donor site complications. Bupiva-
caine is widely used as a long acting local anaesthetic agent in
both surgery and obstetrics and generally has a good safety re-
cord although rarely its use has resulted in fatal cardiotoxicity,
usually after accidental intravascular injection. We used levo-
bupivacaine 2.5 mg/ml, the single enantiomer version of bupi-
vacaine, because it has a long duration of action and clinically
equivalent anaesthetic potency to bupivacaine but with an
improved cardiovascular and neurotoxicity safety profile.16
Ropivacaine also has an equivalent efficacy to bupivacaine
but with less cardiotoxicity.17 All patients were given systemic
analgesia according to our usual clinical practice.Fig. 1 – Photograph to show closed iliac crest wound closed
with drain and local anaesthetic infusion cannula.2. Method
All patients scheduled for anterior iliac crest bone harvesting
for reconstruction of themandible ormaxilla or both, who ful-
filled the inclusion criteria were invited by two of the authors
(PC andRO) to participate in this two-armeddouble blind rand-
omised controlled trial. Ethical Committee approval was
obtained. All patientswere undergoing alveolar bone augmen-
tation to facilitate the subsequent placement of oral implants.
We calculated that 23 patients in each groupwould be required
to detect a difference inmeans of 2.00 (the difference between
the control groupmean pain score of 7.00 and the local anaes-
thetic group mean pain score of 5.00) assuming that the com-
mon standard deviation was 2.00 using an independentsample t-test with a 0.05 two-sided significance level. The sta-
tistical power of the studywas 90%.We recruited 53 patients to
provide 46 evaluable patients and undertook the study at
Central Manchester and Manchester Children’s University
Hospitals NHS Trust from November 2004 to November 2006.
2.1. Inclusion and exclusion criteria
Patients were considered eligible for study inclusion if they
were male or female, aged 18–75 years, ASA I or II, able to un-
derstand and co-operate with the requirements of the proto-
col and able and willing to exercise an appropriate written
informed consent. Patients were excluded from participating
in the study if they had a known hypersensitivity or allergy
to bupivacaine or levobupivacaine or had a history of previous
surgery or injury to the ileum.
2.2. Surgical procedure
Donor site and recipient site surgical procedures were stand-
ardised as far as possible and prophylactic antibiotics were
administered to all patients. At the donor site, the skin inci-
sion was lateral and parallel to the iliac crest followed by dis-
section down through subcutaneous fat to the muscular
aponeurosis. An oblique incision wasmade along the external
oblique aponeurosis, starting 2 cm behind the anterior supe-
rior iliac spine, down onto the ilium. A cortico-cancellous
block was removed from the medial plate using an electric
saw and osteotomes. Cancellous chips were taken with
a gouge. The volume of block and chips was measured by dis-
placement of saline in a measuring syringe. In all patients
a vacuum drain was placed deep against the medial plate
and taken through the skin lateral to the incision. The apo-
neurosis was closed and an epidural cannula (16 g clear cath-
eter Epidural Minipack, Portex Ltd. UK) placed into the wound
superficial to the perioseum inserted through a separate skin
puncture (Fig. 1).
The intraoral recipient surgical site was infiltrated with
5 ml bupivacaine 0.25% with 1:200,000 epinephrine prior to
incisions being made. All surgery was undertaken by two
of the authors (PC and RO). All patients received regular post-
operative systemic analgesia with ibuprofen 400 mg 4–6 h
7 day follow-upmorning day 10-6 hours
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Fig. 2 – Error bars for the mean pain scores over first 6 h, at
1 day, and at 7 days for the two study groups.
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30 mg 4–6 h orally, and morphine 10 mg intramuscularly as
necessary.
2.3. Allocation concealment and blinding
Patients were allocated to the local anaesthetic or placebo
(saline) groupaccording to computer generated randomisation
code slips that were concealed in sealed envelopes and
opened in theatre by the surgeon at the time ofwound closure.
Therandomisationcodewaspreparedbyamedical statistician
(HVW) and held by a research assistant. Local anaesthetic
group patients received 2.5 mg/ml levobupivacaine via the
wound cannula delivered by an infusion pump (attached to
a drip stand) at a rate of 16.25 mg/h (equivalent to 390 mg/
24 h) for 24 h. Those allocated to the placebo group received
an equivalent volume of 0.9% saline at the same infusion
rate. The local anaesthetic was put into an infusion bag identi-
cal in appearance to the placebo infusion bag. The infusion so-
lution was labelled ‘study drug’ with investigator contact
details. The infusion was set up by the surgeon who was not
blind to the group but all postoperative outcome assessments
were undertaken by a research nurse (DJ-L) who was blind to
the study group of the patient.
2.4. Pain measures
Postoperative pain intensity was measured using a 10 cm vi-
sual analogue scale labelled ‘no pain’ to ‘worst pain imagin-
able’ asking the patient to record pain at the hip at rest and
also pain at the recipient site separately. Postoperative pain
was recorded immediately on returning to the ward, then at
1, 2, 3, 4, 5, 6 h, morning and evening on subsequent days until
discharge, and at the out-patient clinic appointment at 7 days.
2.5. Mobility
Postoperativemobility was recorded by gait disturbance, pres-
ence of limp, deviation of gait, unsteadiness and unequalness
of stride, while walking 20 feet, on initial mobilisation, daily
whilst an inpatient and then at the clinic appointment at
7 days.18
2.6. Time to hospital discharge
Length of hospital stay in days was recorded.
2.7. Complications
Any donor site infection, wound dehiscence, presence of hae-
matoma, or sensory disturbance were recorded during the in-
patient stay and at 7 days.
2.8. Statistical methods
Unequal variance independent sample t-tests were used to
compare themean pain scores for the two groups. These tests
use robust standard errors which are Huber/White/sandwich
estimator of variance. For repeat measures data it is incorrect
to conduct tests at each time point, we therefore comparedthe mean pain scores from the initial assessment to the 6-h
assessment, and then compared each successive pain score
at follow-up after 1 day, 2 days and 7 days. Fisher’s exact tests
were used to compare the mobility data between the two
study groups. Further analyses were conducted to investigate
the effects of age, body weight, bone graft size and time of
donor site surgery on pain scores, within each study group,
using Spearman’s correlation coefficients. All statistical tests
were undertaken at the 0.05 level of significance.3. Results
Only one of the 53 patients invited to participate in the study
chose not to participate but another 6 were not randomised as
their surgery was cancelled due to bed availability issues. Of
the 46 patients, 25 were randomised to the levobupivacaine
group and 21 to the control group; 20 (43.5%) were male and
26 (56.5%) were female. None of the 46 patients were lost to
follow-up, although we did not have complete information
on each.
There were no clinically important differences between
localanaesthetic andplacebogroupsatbaseline forage,gender
weight, timeof donor site surgeryor volumeofboneharvested.
The mean age was 33 years (SD14.02) and mean weight was
69.33 kg (SD 13.75). The mean time of donor site surgery was
29.82 min (SD 7.96) and the mean volume of bone harvested
was 7.0 cm3 (SD 4.81).
3.1. Postoperative pain
The error bars for the mean pain scores for the donor site are
shown for the average pain over 6 h, pain in the morning at
day 1 and at day 7 follow up for both groups in Fig. 2. It is
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on all occasions. Unequal variance t-tests were conducted to
compare the mean pain scores for (i) the average pain over
6 h; (ii) pain scores at 1 day post operation in the morning;
(iii) at 1 day post operation in the evening; (iv) at 2 days after
the operation; and (v) at follow-up (Table 1). All of these com-
parisons were statistically significant in favour of lower pain
scores in the levobupivicaine group ( p-values all <0.01).
Therewas a statistically significant difference for themean
pain in the mouth for 0–6 h comparison between groups ( p ¼
0.046), however no other statistically significant differences
for recipient site pain scores between groups were recorded
at any point ( p > 0.05).
Further analyses were carried out in each intervention
group to investigate whether there was an association be-
tween donor site pain and size of donor graft, time taken
and age of patient. From the 30 Spearman’s correlation coeffi-
cients generated only two were significant as follows: pain in
themorning of day 2 and time of surgery for the placebo group
(Spearman’s correlation 0.54, p ¼ 0.015), and pain in the even-
ing of day 1 and time of surgery for the levobupivacaine group
(Spearman’s correlation 0.52, p ¼ 0.032).3.2. Mobility
Comparison between the study groups for mobility found 6
patients unable to get out of bed in the placebo group, com-
pared to none in the local anaesthetic group at the initial as-
sessment (Fisher’s exact test p-value ¼ 0.005), and 2 patients
at the 24-h assessment). Table 2 compares the groups for dif-
ferent measures of mobility at different time periods. The pa-
tients in the local anaesthetic group were alwaysmoremobile
and this was statistically significant even at the 7-day assess-
ment for gait disturbance, limp, deviation of gait and unequal-
ness of stride.
In order to test for associations betweenmobility and bone
volume, timeof surgery, ageofpatientandbodyweight,Mann–
Whitney U-tests were conducted for each group separately, at
each time point. This led to only 4 significant findings, all for
differentmobility andpatient variables, out of the 40 statistical
tests conducted and these p-values were all >0.01. It isTable 1 – Comparisons between the mean pain scores at differ
Placebo
n Mean (SD)
Initial assessment 21 4.21 (2.51)
1 h post op. 21 4.64 (2.97)
2 h post op. 21 4.48 (2.70)
3 h post op. 21 4.05 (3.40)
4 h post op. 21 4.55 (2.77)
5 h post op. 21 4.98 (2.69)
6 h post op. 21 4.71 (2.84)
Mean pain scores 0–6 h 21 4.52 (2.06)
Day 1 post op. (morning) 17 3.76 (2.86)
Day 1 post op. (evening) 17 4.50 (4.18)
Day 2 post op. 18 4.08 (5.19)
Follow-up (7 days) 21 1.45 (1.52)concluded that there is no evidence of an association between
mobility and these factors.
3.3. Time to hospital discharge
All 25 patients in the local aesthetic arm were in hospital for
2 days after surgery. In the placebo group 18 were in hospital
2 days and 3 patients were in hospital 3 days however this dif-
ference was not statistically significant (Fisher’s exact test
p ¼ 0.088). There were insufficient differences in time here to
carry out further analysis to investigate any associations
between bone volume, time of surgery or body weight and
discharge time.
3.4. Complications
None of the patients in our study had any donor site wound
dehiscence, haematoma or sensory disturbance after surgery.
One patient developed a wound infection at 7 days. This
patient was in the placebo group and the infection resolved
with a course of oral antibiotics. As complications were few
in number it was not possible to investigate any group differ-
ence or association with age, body weight, donor graft size, or
length of donor harvest surgery.4. Discussion
4.1. Postoperative pain
Whilst some have recommended different surgical tech-
niques for iliac crest grafting such as anterior versus posterior
sites,3 lateral versusmedial sites,6 or reconstructionwith bone
substitute,8 donor site pain remains a significant postopera-
tive management problem.19 This study showed a clinically
significant decrease in mean postoperative pain scores when
patients received levobupivacaine by continuous wound infu-
sion compared to placebo. This was evident for the immediate
6-h postoperative period and also the day after surgery, the
second day, and even at follow-up 1 week later. We know
that surgical trauma leads to a barrage of nociceptive input
to the central nervous system that increases sensitivity inent time periods
Levobupivacaine p-value from
unequal variance t-test
n Mean (SD)
24 2.29 (1.76) –
25 1.79 (1.77) –
25 1.51 (1.34) –
25 1.26 (1.11) –
25 1.13 (1.07) –
25 0.86 (0.82) –
25 0.98 (1.37) –
24 1.43 (0.87) <0.001
22 1.32 (1.80) 0.005
22 0.95 (1.02) 0.003
21 1.05 (2.15) 0.030
25 0.45 (0.89) 0.012
Table 2 – Comparisons between the study groups for the mobility assessments at different time points
Number with (%) p-value from
Fisher’s exact test
Placebo Levobupivacaine
Initial Gait disturbance 15/18 (83)a 14/22 (64) 0.29
Limp 15/18 (83) 16/22 (73) 0.48
Deviation of gait 13/18 (72) 10/22 (46) 0.12
Unsteadiness 11/18 (61) 6/22 (27) 0.053
Unequalness of stride 10/18 (56) 6/22 (27) 0.11
24 h Gait disturbance 14/18 (78)b 8/21 (38) 0.023
Limp 13/18 (72) 10/21 (48) 0.19
Deviation of gait 11/18 (61) 4/20 (20) 0.019
Unsteadiness 8/18 (56) 1/20 (5) 0.007
Unequalness of stride 6/17 (35) 2/20 (10) 0.11
48 h Gait disturbance 15/18 (83) 7/21 (33) 0.003
Limp 14/18 (78) 10/21 (48) 0.098
Deviation of gait 13/18 (72) 3/21 (14) <0.001
Unsteadiness 7/18 (61) 0/21 (0) 0.002
Unequalness of stride 7/18 (39) 2/21 (10) 0.055
7 days post-operatively Gait disturbance 15/21 (71) 1/24 (4) <0.001
Limp 13/21 (62) 2/24 (8) <0.001
Deviation of gait 8/21 (38) 1/24 (4) 0.007
Unsteadiness 3/21 (14) 1/24 (4) 0.33
Unequalness of stride 6/21 (29) 0/24 (0) 0.007
a Includes 6 people who were immobile.
b Includes 2 people who were immobile.
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utes to the maintenance of postoperative pain.20 Local anaes-
thetics are thought to be useful for blockade of nociceptive
input, reducing central sensitisation and for extending this
blockade into the initial postoperative period, although there
is inconclusive evidence on the beneficial effects of pre-
emptive analgesia on postoperative pain in studies comparing
the timing of intervention.21 Our own study, showing reduced
pain long after this blockade with local anaesthetic, may be
because of reduced sensitisation.
It was encouraging to find that the levobupivacaine pro-
vided improved pain control even though a vacuum drain
was in situ as there are situations when a vacuum drain is es-
sential. We hadmade an attempt to create two compartments
by placing the drain deep, and the local anaesthetic infusion
superficial to, the sutured periosteum, in an attempt to reduce
loss of the anaesthetic solution into the drain, but inevitably
there would have been some solution loss. Surgeons who use
a drain should therefore be reassured that their patients can
benefit from improved pain control although it may be neces-
sary to try and create two compartments when placing the
drain and local anaesthetic infusion. In another study that
demonstrated reduced postoperative pain, 10 ml of 7.5% ropi-
vacainewas administered via the drain 5 min before attaching
to the suction.22 This study of iliac crest harvesting for cervical
fusion did not demonstrate an immediate improvement in
postoperative pain although there was an improvement sev-
eral days later. The study did not investigate mobility or dis-
charge time. A shoulder surgery study demonstrating lower
pain scores 3 months after surgery in addition to the immedi-
ate period used a continuous infusion of 0.2% ropivacaine to
the donor site.23 Again this study did not investigate mobility
or discharge time. Another study demonstrating long-term,6 months, improved pain scores used a 0.25% bupivacaine
donor site infusion although this studywas not randomised.24
Patients in our study did still experience more postopera-
tive pain than we would have anticipated as we already used
a systemic analgesic protocol that we had developed to
improve our patients’ postoperative pain experience.25 All
patients received ibuprofen, paracetamol and codeine and
morphine unless contraindicated. We had wondered whether
a local anaesthetic infusionwas really necessary aswe already
used this systematic analgesic protocol but this study has
highlighted the importance of using additional pain control
methods and in particular, wound infusion with local
anaesthetic.
Patients undergoing simultaneous surgery involving two
body sites are likely to have pain from the two sites and this
may influence the patients’ report of pain for one of the sites.
In this study we asked the patients to record their pain inten-
sity at both sites independently. There was not only a signifi-
cant difference in pain scores by group at the donor site but
also at the recipient site over the first 6 h postoperatively al-
though not at any of the later time points. It was interesting
to find that for the early period after surgery, when the pain
scores were at their highest, patients report of face pain was
influenced by their experience of hip pain. If patients received
the local anaesthetic infusion, they reported less hip pain but
also less face pain even though all study patients received the
same local anaesthetic at the recipient site. This may the first
report of such an association.
We found little association between postoperative pain
scores and the size of bone graft harvested from the hip or
the time taken for the surgery. This was not unexpected as
the surgery in this studywas fairly standardisedwith a limited
range of graft size and surgical time. Neither has any
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fusion been demonstrated.22 We also found little association
between postoperative pain scores and the age of the patient.
4.2. Mobility
We found a significant difference overall for themobilitymea-
sures between the group that received the levobupivacaine
and the group receiving placebo in favour of receiving the local
anaesthesia. This has implications for the convenience of the
patient but also their safety. Patients are likely to prefer the in-
dependence offered by comfortable early mobility that may
allow them to care for themselves. Six patients in the placebo
groupwere unable to get out bed at the time of the first assess-
ment in the evening of surgery because of pain on moving.
Two were still unable to get out of bed at 24 h. This is of con-
cern because of the increased risk of deep vein thrombosis
(DVT) when postoperative mobility is impaired.26,27
We did not find any association between the size of bone
graft harvested from the hip or the time taken for the surgery
and mobility. However as discussed above there was little
variation in size of graft or time of surgery. We also found
no association between the age or body weight of the patient
and mobility.
4.3. Time to hospital discharge
Nearly all patients required two postoperative nights recovery
in hospital prior to discharge home. Three patients had their
planned discharge delayed by 1 day in the placebo group and
no patients had their discharge delayed in the local anaes-
thetic group. However, this differencewas not statistically sig-
nificant. Another study28 has also investigated average length
of stay after iliac crest graft, for spinal fusion, and found no
significant difference when hip wound infusion was with
0.5% bupivacaine or saline. This randomised clinical trial
was well conducted. Patient discharge may be delayed as
a consequence of inadequately controlled pain, need for mor-
phine analgesia, or reduced mobility amongst other possible
factors and this will have significant economic implications
for the health service but we did not show any significant
group advantage in our study.
There were insufficient group differences in time to dis-
charge to carry out any analysis of association with size of
bone graft, time of surgery, age or body weight.
4.4. Complications
None of the patients in this study had any donor site wound
dehiscence, haematoma or sensory disturbance after surgery.
One patient developed a wound infection at 7 days. Our com-
plication rate was low compared to some reports29 but our
study was not powered to investigate complications as this
was not our outcome of primary interest. It was however
encouraging that within the constraints of our number of
patients that the local anaesthetic infusion did not lead to
wound dehiscence or other local complication. Altered sensa-
tion in the distribution of the lateral femoral cutaneous, ilioin-
guinal, ormiddleand superior clunealnerve iswell recognised.
Objective testing in one study showed that a significantimpairment of sensory function found at 1 week had a ten-
dency towards recovery after 1 month.3 However, the develop-
mentofneuropathicpainhasbeendescribedasaconsequence
of damage to these sensory nerves.305. Conclusion
Continuous infusion of iliac crest wounds with 2.5 mg/ml lev-
obupivacaine16.25 mg/h (equivalent to 390 mg/24 h) for 24 h
significantly reduced postoperative pain and improvedmobil-
ity. There were no complications relating to the infusion sys-
tem in the 46 patients in this study. We did not find any
association between the size of bone graft harvested from
the hip, time taken for the surgery, patient age or body weight
and postoperative pain andmobility. We were unable to dem-
onstrate any significant difference in the time to hospital dis-
charge for the local anaesthetic group. We recommend that
surgeons use such a local anaesthetic infusion to improve
the postoperative experience for their patients undergoing
iliac crest harvesting.Conflicts of interest
None.
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